These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9119622)

  • 1. Healthy years equivalents versus time trade-off. Ambiguity on certainty and uncertainty.
    Rittenhouse BE
    Int J Technol Assess Health Care; 1997; 13(1):35-48. PubMed ID: 9119622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HYE (healthy years equivalent) and TTO (time trade-off): what is the difference?
    Morrison GC
    J Health Econ; 1997 Oct; 16(5):563-78. PubMed ID: 10175631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A note on HYE (healthy years equivalent).
    Buckingham K
    J Health Econ; 1993 Oct; 12(3):301-9. PubMed ID: 10145202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are healthy-years equivalents an improvement over quality-adjusted life years?
    Johannesson M; Pliskin JS; Weinstein MC
    Med Decis Making; 1993; 13(4):281-6. PubMed ID: 8246699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ranking properties of healthy-years equivalents and quality-adjusted life-years under certainty and uncertainty.
    Johannesson M
    Int J Technol Assess Health Care; 1995; 11(1):40-8. PubMed ID: 7706013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A (Latent) Class of Their Own: Response Patterns in Trading Off Quantity and Quality of Life in Time Trade-Off Exercises.
    van Nooten FE; Houghton K; van Exel J; van Agthoven M; Brouwer WBF; Stull DE
    Value Health; 2017 Dec; 20(10):1403-1410. PubMed ID: 29241900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time trade-off utility modified to accommodate degenerative and life-threatening conditions.
    Kattan MW; Fearn PA; Miles BJ
    Proc AMIA Symp; 2001; ():304-8. PubMed ID: 11825200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The standard gamble method: what is being measured and how it is interpreted.
    Gafni A
    Health Serv Res; 1994 Jun; 29(2):207-24. PubMed ID: 8005790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality-adjusted life years, utility theory, and healthy-years equivalents.
    Mehrez A; Gafni A
    Med Decis Making; 1989; 9(2):142-9. PubMed ID: 2501627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The healthy-years equivalents: how to measure them using the standard gamble approach.
    Mehrez A; Gafni A
    Med Decis Making; 1991; 11(2):140-6. PubMed ID: 1865782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthy-years equivalents versus quality-adjusted life years: in pursuit of progress.
    Mehrez A; Gafni A
    Med Decis Making; 1993; 13(4):287-92. PubMed ID: 8246700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preference based outcome measures for economic evaluation of drug interventions: quality adjusted life years (QALYs) versus healthy years equivalents (HYEs).
    Mehrez A; Gafni A
    Pharmacoeconomics; 1992 May; 1(5):338-45. PubMed ID: 10146998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthy-years equivalent: wounded but not yet dead.
    Hauber AB
    Expert Rev Pharmacoecon Outcomes Res; 2009 Jun; 9(3):265-9. PubMed ID: 19527099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The validity of time trade-off values in calculating QALYs: constant proportional time trade-off versus the proportional heuristic.
    Dolan P; Stalmeier P
    J Health Econ; 2003 May; 22(3):445-58. PubMed ID: 12683961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economics, health and health economics: HYEs (healthy-years equivalent) versus QALYs (quality-adjusted live-year).
    Gafni A; Birch S; Mehrez A
    J Health Econ; 1993 Oct; 12(3):325-39. PubMed ID: 10129840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examination of assumptions in using time tradeoff and standard gamble utilities in individuals with spinal cord injury.
    Lin MR; Yu WY; Wang SC
    Arch Phys Med Rehabil; 2012 Feb; 93(2):245-52. PubMed ID: 22289233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valuing Treatments for Parkinson Disease Incorporating Process Utility: Performance of Best-Worst Scaling, Time Trade-Off, and Visual Analogue Scales.
    Weernink MG; Groothuis-Oudshoorn CG; IJzerman MJ; van Til JA
    Value Health; 2016; 19(2):226-32. PubMed ID: 27021757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of subjective life expectancy on health state valuations using a 10 year TTO.
    van Nooten FE; Koolman X; Brouwer WB
    Health Econ; 2009 May; 18(5):549-58. PubMed ID: 18702082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health years equivalents as a measurement of preferences for dental interventions.
    Birch S; Gafni A; Markham B; Marriott M; Lewis D; Main P
    Community Dent Health; 1998 Dec; 15(4):233-42. PubMed ID: 9973723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QALYs, HYEs and individual preferences--a graphical illustration.
    Johannesson M
    Soc Sci Med; 1994 Dec; 39(12):1623-32. PubMed ID: 7846559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.